← Back to News

Treatment with SQ3370, a doxorubicin-based click chemistry therapeutic, promotes immune activation in the tumor microenvironment

November 7, 2022

View the presented poster here

Want to stay up to date on our news? 
Follow us on LinkedIn
Company
About UsLeadershipOur platformPipeline
Connect
NewsCareersContact
Policies
Privacy PolicyFCOI Policy